WHO ICTRP trial
Study of the association of docetaxel and liposomial doxorubicin Myocet in…
EUCTR2006-000120-14-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2006-000120-14-IT |
|---|---|
| Public title | Study of the association of docetaxel and liposomial doxorubicin Myocet in metastatic breast cancer phase II clinical trial - ND |
| Scientific title | Study of the association of docetaxel and liposomial doxorubicin Myocet in metastatic breast cancer phase II clinical trial - ND |
| Primary sponsor | AZIENDA USL 6 LIVORNO ZONA LIVORNESE |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | Patiens with metastatic breast cancer MedDRA version: 6.1 Level: PT Classification code 10055113 |
| Interventions | Trade Name: MYOCET IV 2 SET/3 FLAC.50 MG Pharmaceutical Form: Powder and solvent for suspension for injection INN or Proposed INN: Doxorubicin CAS Number: 25316-40-9 Concentration unit: mg milligram(s) Concentration type: equal… |
| Registration date | Mar 14, 2006 |
| Target size | 41 |
| Secondary IDs | ASL605LIOM01 MYTA |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: